CLINIC-IN-THE-LOOP

Summary from the TLDR newsletter

Biomedical progress has become less productive for the last several years despite staggering advances in basic science. One of the reasons for this is that institutional bureaucracy has become harder to overcome. Increasing the number and efficiency of clinical trials would help create a faster feedback loop and result in better data to inform models and ideas. This could help decrease the cost of bringing new drugs to market and break a trend that has held since the 1950s.